Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
- PMID: 1465616
- DOI: 10.1126/science.1465616
Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
Abstract
Impaired immune responses occur frequently in cancer patients or in tumor-bearing mice, but the mechanisms of the tumor-induced immune defects remain poorly understood. In an in vivo murine colon carcinoma model (MCA-38), animals bearing a tumor longer than 26 days develop CD8+ T cells with impaired cytotoxic function, decreased expression of the tumor necrosis factor-alpha and granzyme B genes, and decreased ability to mediate an antitumor response in vivo. T lymphocytes from tumor-bearing mice expressed T cell antigen receptors that contained low amounts of CD3 gamma and completely lacked CD3 zeta, which was replaced by the Fc epsilon gamma-chain. Expression of the tyrosine kinases p56lck and p59fyn was also reduced. These changes could be the basis of immune defects in tumor-bearing hosts.
Comment in
-
Do tumor-altered T cells depress immune responses?Science. 1992 Dec 11;258(5089):1732-3. doi: 10.1126/science.1465609. Science. 1992. PMID: 1465609 No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials